Business · 18/04/2000Updated: 10/17/2026 · 1 min read
FDA Approves Injectable Hemoglobin Treatment for Canine Anemia
Summary
The US Food and Drug Administration (FDA) is updating its regulations to reflect the approval of a new application for Biopure Corp.'s hemoglobin glutamer-200 (bovine), a treatment for anemia in dogs, allowing for flexible dosing. This change aims to provide more treatment options for canine anemia.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →